Fox Run Management’s Intersect ENT, Inc XENT Stock Holding History

Fox Run Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,153	Closed	-$635K	–	981
2018 Q1	$635K	Buy	+16,153	New	+$590K	0.15%	235

Other funds holding XENT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fox Run Management's XENT Position: Q2 2018 in Review

Fox Run Management sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 16,153 shares — an estimated $635K sold.

Fox Run Management first reported a position in XENT in Q1 2018 and held it in 1 quarter. The position peaked at $635K in Q1 2018. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

Fox Run Management reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
Fox Run Management sold 16,153 Intersect ENT, Inc shares in Q2 2018, an estimated $635K.
Fox Run Management first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 1 quarter.
Fox Run Management's Intersect ENT, Inc position peaked at $635K in Q1 2018.
160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Fox Run Management's 13F filing for Q2 2018, filed 17 Jul 2018.